The Hypopara Research Study
Recruitment Closed
3 Jun 2026
Up to $7,800
Melbourne, Australia
We’re launching a new clinical study exploring an investigational treatment designed for people living with hypoparathyroidism. This rare condition can disrupt the body’s calcium balance, often leading to muscle cramps, tingling, fatigue, and other daily challenges.
Our study focuses on a potential new therapy that aims to restore healthier parathyroid hormone function and improve overall quality of life. By participating, volunteers may help advance research that could lead to new treatment options for the broader hypoparathyroidism community.
This new treatment is being developed because current options for hypoparathyroidism have some major limitations. Right now, most people have to take large amounts of calcium and active vitamin D every day to keep their blood calcium levels stable. While these supplements can help prevent low calcium, they don’t replace the parathyroid hormone (PTH) that the body is missing. As a result, this approach can be hard to manage and may cause other issues over time.
Join our clinical trial
This is a first-in-human (FIH) study, meaning it is the first time the potential treatment is being tested in people. The study has been carefully designed with strict safety protocols and has been approved by an independent ethics committee. It is not known whether the study drug may cause unexpected, serious, or life-threatening side effects. While these are considered unlikely, you will be carefully monitored throughout the study and provided with prompt treatment if any such effects occur.
Before joining, you’ll receive detailed information about the study, meet with a doctor, and have the chance to ask any questions.
What to expect
- Participation in a monitored clinical environment
- Study visits scheduled
- Support from a professional medical team
- Reimbursement for your time and commitment
Trial details
Study medication
Administered as an oral capsule.
Study duration
15 nights stay, 1 follow-up visit.
Additional eligibility
- Non-smokers or smoking less than 5 cigarettes per
week
Ethics
This study has been reviewed and approved by an independent ethics committee.
Are you a match?
Age
21 - 60 years old
Remuneration
Up to $7,800 *with screening reimbursement.
Full details outlined in consent form.
Gender
Male, Female or Female (Post-menopausal)
BMI
BMI 18 - 32 kg/m2
Commitment
15 nights, 1 clinic visit